## Session overview INTC led the after-midnight gainers with a rise of about 12.14%, followed by META up roughly 11.34%, AMD higher by approximately 9.95%, QCOM gaining about 9.29%, and TME adding roughly 5.28%. On the downside, XOM fell about 3.20%, CVX

Verdict: The dip-buy setup is real, but today is a watch day, not a buy day

The core dip-and-reclaim structure has genuine support: the completed nine-month backtest on the AMD dependency returned about 47.9% over six trades with an 83% win rate against a 19.2% peak-to-trough drawdown, and the four traded names — AMD, INTC, QCOM, META — all showed accelerating Q2 fundamentals alongside the reversal tape. But the setup is not live on any name today: INTC, AMD, META, and QCOM are all stretched with RSI readings between 77.5 and 87.5 and need pullbacks toward their Bollinger middles, while the closest candidate, CVS, sits about 2 RSI points from trigger with fundamentals improving (Q2 revenue up 5.7% to $106.1B, free cash flow up 66% to $5.65B). The single most powerful counterweight is ownership posture — filings for the period ended June 30, 2026 show net insider selling in every traded name, roughly $176M in AMD, $55M in META, and $65M in INTC — and exits were filled on daily trigger bars, so the reported 19.2% drawdown and win rate are coarse. Meanwhile the defensives' entries (CVS, and XOM at RSI 26.8 about 18 points from its crossover) are multi-day events, not multi-hour ones. A fresh ownership cycle showing insiders flipping to net buying, or a documented news catalyst behind the INTC jump, would materially raise conviction; the current read is wait with alerts at the levels above.

Trade now: wait — the entries are close on two names, far on the rest

Nothing is actionable at this moment, and that is the correct read. The strategy waits for a dip-and-reclaim: price above the 50-period EMA, a low that tags the middle Bollinger band, and RSI (14) crossing back above 45 while staying below 65. Of the four traded names, **CVS is closest to triggering** — its RSI (14) is at 43.0, only about 2 points below the 45 crossover level, and price (94.46) is already below its Bollinger middle (95.32) with the 50 EMA at 95.85 just 1.39 away. INTC also has all conditions marked near or met on price but its RSI at 77.5 is well above the 65 cap, so it needs a pullback first. The other names are not in play. AMD's RSI is at 85.6 with price at 615.36 — roughly 46 points above its Bollinger middle — and META at 743.33 with RSI 87.5 is the most stretched; both need meaningful pullbacks before any entry can form. QCOM sits in between: price at 195.25 is above its 50 EMA (182.39) and near its Bollinger middle (186.58), but RSI at 77.7 is far above 45, so wait. If an entry triggers, the exit framework is explicit: a stop at a 2.4% loss, a first profit target at 4.7%, or an exit after 60 daily bars. That is roughly a 2-to-1 reward-to-risk per position, with positions sized to fixed 2.35% risk and capped at 25% of the book per name. "Wait" concretely means: no positions today, alerts set at the levels in the watch table, and a re-check of RSI versus 45 after the next daily close on CVS and QCOM. On evidence: the completed 9-month backtest run on the AMD dependency returned 47.9% across 6 trades with an 83% win rate and a 19.2% maximum drawdown, which supports the dip-buy structure. One caveat for planning: the parameter-sensitivity evaluation ran out of its time budget before testing any variants, so no robust alternative parameter setup was established — trade the published setup as written rather than improvising tweaks.

The momentum cluster has fundamentals behind it — and a nine-month backtest to lean on

The bull case starts with what the backtest actually delivered. Over the nine-month evaluated window, the strategy completed 6 trades on the AMD@1d pair with an 83.3% win rate and a cumulative return of roughly 47.9%, against a maximum drawdown of about 19.2%. The equity curve shows the drawdown concentrated early — the account was down over 10% in the first stretch of the window — before the cluster of big AMD-led trades recovered it and pushed equity to a peak of about 48%. For a long-bias momentum setup, a reward that arrived after surviving an early losing streak is the more honest version of the story than a smooth curve would be. The setup is not trading against the fundamentals of its four names. AMD's Q2 revenue hit $11.5B, up 12.5% quarter over quarter, with net income up 66% to $2.3B and net margin expanding from 13.5% to 19.9%. INTC's Q2 revenue rose 18.8% to $16.1B with a swing back to positive operating margin of 11.1%, and QCOM's Q2 printed a 69.5% net margin on $10.6B in revenue. META grew Q2 revenue 8% to $60.8B. The recent session tape the idea flags — INTC up 12.1%, META up 11.3%, AMD up 10%, QCOM up 9.3% — is a reversal session in the same names that just showed accelerating earnings, which is the pattern a breakout long wants. Ownership posture is broadly consistent with the momentum case: institutional holders are present across all four traded names (25 reporters covering AMD, 31 for META, 27 for INTC, 17 for QCOM), so there is a real shareholder base around these moves rather than a thin float. The four traded names are all liquid mega-caps across Information Technology and Communication Services, so the intraday reversal dynamics the idea describes should be executable without spread or liquidity concerns. Because these are mega-caps in two adjacent sectors, some cross-stock correlation is expected; the dedicated cross-stock section addresses how much of the move is shared versus idiosyncratic. On the evidence supplied, the thesis — that the chip complex plus META is in a tradable breakout regime — is supported by both the trade history and the underlying earnings trend.

One symbol carried the returns, insiders are selling everywhere, and the energy side of the tape disagrees

The bear case begins with concentration. Of the four traded dependencies, only the AMD@1d pair actually traded in the evaluated nine-month window — all six trades and essentially all of the 47.9% return trace to AMD's share-price trajectory. AMD is a high-beta semiconductor stock that has previously drawn down hard: its own Q2 2025 quarter showed gross margin collapsing from 50.2% to 39.8% and operating margin going negative, a reminder that this name can deteriorate quickly. A strategy whose returns hinge on one such name is exposed to exactly that kind of single-quarter shock. The drawdown math deserves plain language: this stock pair endured a peak-to-trough decline of roughly 19.2% within the window, with the account sitting down more than 10% for a stretch of several months before recovery. A position-sizing plan risking about 2.4% per trade still produced that equity path. Note also that exit fills were evaluated on daily trigger bars, not intrabar data, so the reported win rate and drawdown are coarse approximations and may overstate exit quality. Insider and ownership posture is uniformly negative. Every one of the traded names shows net open-market insider selling in filings for the period ended June 30, 2026: roughly $176M net selling in AMD, $55M in META, $65M in INTC, and $9.3M in QCOM. Corporate insiders are not buying the breakout the strategy is chasing. The wider panel undercuts the idea's framing that this was a clean reversal session. XOM fell 3.2% and CVX slipped 2.8%, and the energy complex's fundamentals are weakening: XOM's Q1 2026 net income dropped 35.7% to $4.2B and free cash flow fell 57.3% to $2.2B, while CVX Q1 free cash flow was negative at -$1.5B. MO's Q2 free cash flow fell 70.3% to $662M and its return on equity is deeply negative at -86%. META itself showed the fragility on the other side: Q2 2026 free cash flow collapsed 86.8% to $1.7B and net margin compressed from 47.5% to 26.1%, even as revenue grew. Parameter-sensitivity evaluation exceeded its time budget, so no robust nearby-parameter setup was established for the live rules. Finally, the strategy's take-profit and stop levels (roughly +4.7% and -2.4%) cap the reward per trade well below the magnitude of the swings these stocks produce, meaning a single gap through the stop on a high-volatility name can hurt more than the backtest's daily-bar fills suggest.

Company context

### AMD **Ownership and insiders.** For the period ending 2026-06-30, 25 reporting holders were counted holding 84534890 reported shares. Insider filings indicate net open-market selling, netting US$-176175867.7. Coverage: Deadline Passed. **Management.** Dr. Lisa T. Su Ph.D. is identified as chief executive. Dr. Lisa T. Su Ph.D. is listed as Chair, President & CEO, with reported total pay of US$4.5M for fiscal 2025. Source: [Yahoo Finance quoteSummary](https://finance.yahoo.com/quote/AMD/profile), retrieved 2026-09-24T10:31:17.64+00:00. **Dividends.** The provider's ten-year corporate-action history contains no cash dividend payments. Source: [Yahoo Finance corporate actions](https://finance.yahoo.com/quote/AMD/history?filter=div), retrieved 2026-09-24T10:31:17.64+00:00. **Fundamental changes.** Latest reported comparisons: - Debt to equity: 0.05x for Q2 ending 2026-06-27 versus 0.05x for Q1 ending 2026-03-28 (-4.0%) · quarter over quarter - Free cash flow: USD 1.6B for Q2 ending 2026-06-27 versus USD 2.6B for Q1 ending 2026-03-28 (-39.3%) · quarter over quarter - Gross margin: 53.7% for Q2 ending 2026-06-27 versus 52.8% for Q1 ending 2026-03-28 (+0.9 percentage points) · quarter over quarter - Net Income: USD 2.3B for Q2 ending 2026-06-27 versus USD 1.4B for Q1 ending 2026-03-28 (+66.1%) · quarter over quarter - Net margin: 19.9% for Q2 ending 2026-06-27 versus 13.4% for Q1 ending 2026-03-28 (+6.4 percentage points) · quarter over quarter - Operating Cash Flow: USD 2.4B for Q2 ending 2026-06-27 versus USD 3.0B for Q1 ending 2026-03-28 (-19.9%) · quarter over quarter - Operating margin: 17.2% for Q2 ending 2026-06-27 versus 14.3% for Q1 ending 2026-03-28 (+2.9 percentage points) · quarter over quarter - Revenue: USD 11.5B for Q2 ending 2026-06-27 versus USD 10.3B for Q1 ending 2026-03-28 (+12.5%) · quarter over quarter - Return on equity: 3.4% for Q2 ending 2026-06-27 versus 2.1% for Q1 ending 2026-03-28 (+1.3 percentage points) · quarter over quarter - Shares Outstanding: 1.6B shares for Q2 ending 2026-06-27 versus 1.6B shares for Q1 ending 2026-03-28 (+0.1%) · quarter over quarter Source: Reported company financial data. Comparisons use consecutive reported periods at the same cadence and compatible units. Relative percentage changes require a positive baseline; rate changes are expressed in percentage points. ### CVS **Ownership and insiders.** For the period ending 2026-06-30, 13 reporting holders were counted holding 71536428 reported shares. Insider filings indicate net open-market selling, netting US$-171646137.37. Coverage: Deadline Passed. **Management.** Mr. J. David Joyner CEBS is identified as chief executive. Mr. J. David Joyner CEBS is listed as CEO, President & Chairman, with reported total pay of US$6.6M for fiscal 2025. Source: [Yahoo Finance quoteSummary](https://finance.yahoo.com/quote/CVS/profile), retrieved 2026-09-24T10:31:17.64+00:00. **Dividends.** Trailing twelve-month distributions total USD 2.66 per share; the latest observed ex-date was 2026-07-23 at USD 0.665 per share. The latest annual comparison is +0.0%. Source: [Yahoo Finance corporate actions](https://finance.yahoo.com/quote/CVS/history?filter=div), retrieved 2026-09-24T10:31:17.64+00:00. **Fundamental changes.** Latest reported comparisons: - Free cash flow: USD 5.7B for Q2 ending 2026-06-30 versus USD 3.4B for Q1 ending 2026-03-31 (+66.3%) · quarter over quarter - Gross margin: 44.5% for Q2 ending 2026-06-30 versus 44.7% for Q1 ending 2026-03-31 (-0.3 percentage points) · quarter over quarter - Net Income: USD 3.0B for Q2 ending 2026-06-30 versus USD 2.9B for Q1 ending 2026-03-31 (+1.2%) · quarter over quarter - Net margin: 2.8% for Q2 ending 2026-06-30 versus 2.9% for Q1 ending 2026-03-31 (-0.1 percentage points) · quarter over quarter - Operating Cash Flow: USD 6.3B for…

Scores

• Conviction score breakdown: 57
• Thesis support: 70
• Trade readiness: 35
• Risk quality: 60
• Backtest evidence: 55
• Fundamentals trend: 65

Watch items

• CVS — RSI (14)
• CVS — Price vs 50 EMA
• TME — RSI (14)
• XOM — Price vs 50 EMA
• INTC — RSI (14)
• META — RSI (14)
• QCOM — RSI (14)
• AMD — Insider ownership flow
• INTC — Debt-to-equity ratio